Consolidated FX-neutral EBITDA Growth
In the second quarter, Auna achieved a 5% growth in consolidated FX-neutral EBITDA, with contributions from Mexico, Colombia, and Peru.
Peru's Performance in Healthcare and Oncology
Peru's healthcare services saw a 5% revenue growth driven by increased surgery volumes and price increases. OncoSalud, the health plan side, delivered solid revenue and EBITDA growth, achieving a record low oncology MLR.
Mexico's Revenue Growth
Mexico's revenue grew 5% year-over-year, driven by higher average tickets for surgeries and emergency treatments, despite market softness.
Colombia's Improved EBITDA and Margin
Colombia's EBITDA increased by 9%, and margin expanded by 1.4 percentage points year-over-year, with a more profitable mix of payers and improved payment flows.
Stable Financial Position
Auna maintained a healthy debt structure and improved its maturity profile by refinancing over $62 million of short-term debt.